Affiliation:
1. Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University
Abstract
Abstract
Objective: To evaluate the clinical significance of the preoperative plasma lipid profile, including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), in patients with lung adenocarcinoma (LUAD) status post complete resection.
Methods: Clinical data, including preoperative plasma profile levels, were retrospectively collected and reviewed in 304 patients with LUAD who underwent radical lung resection between 2016–2017. The overall survival (OS) and disease-free survival (DFS) were assessed by the Kaplan–Meier method and the Cox proportional hazards regression model.
Results: TC ≤ 3.58 and HDL-C ≤ 1.01 were deemed as independent preoperative risk factors for OS, and HDL-C ≤ 1.01 was an independent preoperative risk factor for DFS. In the multivariate analyses involving OS and DFS, an increased TC level (HR, 0.504; 95% CI, 0.324–0.782, P = 0.002) was significantly associated with better OS. Additionally, a decreased HDL-C level was significantly associated with worse OS (HR, 0.665; 95% CI, 0.443–0.999, P = 0.049) and DFS (HR, 0.619; 95% CI, 0.420–0.912, P = 0.015).
Conclusions: In patients with LUAD, increased TC levels may predict better OS, while decreased levels of HDL-C may predict worse outcomes for both DFS and OS.
Publisher
Research Square Platform LLC
Reference34 articles.
1. Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma;Bischoff P;Oncogene,2021
2. Li F, Niu Y, Zhao W, Yan C, Qi Y. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes.Sci Rep. 2022 Nov18;12(1):19857.
3. Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma;Li X;Front Oncol,2021
4. Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma;Gao S;Cancer Sci,2022
5. Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance;Zhang L;J Cancer,2020